Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2022
Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organsNathaniel R Kastan, Sanyukta Oak, Rui Liang, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 13, 2024
Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally advanced pancreatic adenocarcinomaAlden D'Souza, Hayley B Stowe, Olga L Green, et al.ACS Medicinal Chemistry Letters|March 18, 2022
A Chemical Strategy toward Novel Brain-Penetrant EZH2 InhibitorsRui Liang, Daisuke Tomita, Yusuke Sasaki, et al.Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.ACS Infectious Diseases|February 2, 2021
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding InteractionsJohn Ginn, Xiuju Jiang, Shan Sun, et al.Biorxiv : the Preprint Server for Biology|March 17, 2025
A potent and selective TNKS2 inhibitor for tumor-selective WNT suppressionJill Zimmerman, Brandon F Malone, Efrat Finkin-Groner, et al.Journal of Medicinal Chemistry|June 11, 2019
Improvement of Asparagine Ethylenediamines as Anti-malarial Plasmodium-Selective Proteasome InhibitorsWenhu Zhan, Joseph Visone, Tierra Ouellette, et al.Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.Journal of Medicinal Chemistry|May 5, 2021
Macrocyclic Peptides that Selectively Inhibit the Mycobacterium tuberculosis ProteasomeHao Zhang, Hao-Chi Hsu, Shoshanna C Kahne, et al.Angewandte Chemie (International Ed. in English)|January 12, 2021
Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized MiceWenhu Zhan, Hao Zhang, John Ginn, et al.Pageof 3